Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 29-Jan-20 4:15 PM View:  | Scheer David Director | Achillion Pharmaceuticals, ... (ACHN) | 28-Jan-20 | Disposition | 29,515 | $6.30 | $185,944.00 | (32%) 92.76K to 63.25K | |
| 29-Jan-20 4:14 PM View: | Graves Kurt Director | Achillion Pharmaceuticals, ... (ACHN) | 28-Jan-20 | Disposition | 22,709 | $6.30 | $143,067.00 | (100%) 22.71K to 0 | |
| 29-Jan-20 4:15 PM View: | Manning Martha E General Counsel | Achillion Pharmaceuticals, ... (ACHN) | 28-Jan-20 | Disposition | 2,500 | $6.30 | $15,750.00 | (100%) 2.5K to 0 | |
| 29-Jan-20 5:30 PM View: | Vitullo Nicole Director | Achillion Pharmaceuticals, ... (ACHN) | 28-Jan-20 | Disposition | 36,431 | $6.30 | $229,515.00 | (1%) 3.45M to 3.42M | |
| 29-Jan-20 4:16 PM View: | van Nostrand Robert L Director | Achillion Pharmaceuticals, ... (ACHN) | 28-Jan-20 | Disposition | 40,000 | $6.30 | $252,000.00 | (100%) 40.0K to 0 | |
| 29-Jan-20 4:15 PM View: | Scheer David Director | Achillion Pharmaceuticals, ... (ACHN) | 28-Jan-20 | Disposition | 63,249 | $6.30 | $398,469.00 | (100%) 63.25K to 0 | |
| 29-Jan-20 4:13 PM View: | Fisherman Jason S Director | Achillion Pharmaceuticals, ... (ACHN) | 28-Jan-20 | Disposition | 90,000 | $6.30 | $567,000.00 | (98%) 91.5K to 1.5K | |
| 29-Jan-20 4:15 PM View: | Truitt Joseph Chief Executive Officer Director | Achillion Pharmaceuticals, ... (ACHN) | 28-Jan-20 | Disposition | 3,500 | $6.30 | $22,050.00 | (100%) 3.5K to 0 | |
| 29-Jan-20 5:30 PM View: | Vitullo Nicole Director | Achillion Pharmaceuticals, ... (ACHN) | 28-Jan-20 | Disposition | 3,418,540 | $6.30 | $21,536,800.00 | (100%) 3.42M to 0 | |
| 30-Jan-20 5:15 PM View: | G1 Execution Services, LLC 10% Owner | Achillion Pharmaceuticals, ... (ACHN) | 28-Jan-20 | Disposition (other) | 14,126,400 | $6.30 | $88,996,400.00 | (100%) 14.13M to 0 | |
| 29-Jan-20 4:13 PM View: | Fisherman Jason S Director | Achillion Pharmaceuticals, ... (ACHN) | 28-Jan-20 | Disposition | 1,500 | $6.30 | $9,450.00 | (100%) 1.5K to 0 | |
| 19-Dec-19 5:33 PM View: | van Nostrand Robert L Director | Achillion Pharmaceuticals, ... (ACHN) | 18-Dec-19 | Option Exercise | 20,000 | $3.28 | $65,600.00 | 100% 20.0K to 40.0K | |
| 14-Nov-19 6:47 PM View: | Fisherman Jason S Director | Achillion Pharmaceuticals, ... (ACHN) | 14-Nov-19 | Option Exercise | 20,000 | $3.28 | $65,600.00 | 28% 71.5K to 91.5K | |
| 14-Nov-19 6:46 PM View: | Scheer David Director | Achillion Pharmaceuticals, ... (ACHN) | 13-Nov-19 | Option Exercise | 20,000 | $3.28 | $65,600.00 | 24% 83.25K to 103.25K | |
| 14-Nov-19 6:46 PM View: | Scheer David Director | Achillion Pharmaceuticals, ... (ACHN) | 13-Nov-19 | Private Option Sale | 10,485 | $6.31 | $66,197.00 | (10%) 103.25K to 92.76K | |
| 18-Oct-19 5:13 PM View: | Truitt Joseph Chief Executive Officer Director | Achillion Pharmaceuticals, ... (ACHN) | 16-Oct-19 | Private Option Sale | 133,484 | $6.37 | $850,947.00 | (97%) 136.98K to 3.5K | |
| 18-Oct-19 5:13 PM View: | Truitt Joseph Chief Executive Officer Director | Achillion Pharmaceuticals, ... (ACHN) | 16-Oct-19 | Option Exercise | 133,484 | $3.14 | $419,785.00 | 3814% 3.5K to 136.98K | (7%) |
| 18-Dec-18 4:22 PM View: | van Nostrand Robert L Director | Achillion Pharmaceuticals, ... (ACHN) | 14-Dec-18 | Option Exercise | 20,000 | $1.05 | $21,000.00 | 100% 0 to 20.0K | |
| 18-Dec-18 4:24 PM View: | Scheer David Director | Achillion Pharmaceuticals, ... (ACHN) | 14-Dec-18 | Option Exercise | 20,000 | $1.05 | $21,000.00 | 32% 63.25K to 83.25K | |
| 08-Jun-18 4:15 PM View: | Fisherman Jason S Director | Achillion Pharmaceuticals, ... (ACHN) | 06-Jun-18 | Option Exercise | 20,000 | $1.05 | $21,000.00 | 39% 51.5K to 71.5K | |
| 04-Jun-18 4:20 PM View: | Vitullo Nicole Director | Achillion Pharmaceuticals, ... (ACHN) | 31-May-18 | Acquisition (other) | 5,000 | -- | -- | < 1% 3.47M to 3.48M | |
| 04-Jun-18 4:20 PM View: | Vitullo Nicole Director | Achillion Pharmaceuticals, ... (ACHN) | 31-May-18 | Disposition (other) | 25,000 | -- | -- | (< 1%) 3.48M to 3.45M | |
| 22-Nov-17 11:44 AM View: | Johnson & Johnson 10% Owner | Achillion Pharmaceuticals, ... (ACHN) | 20-Nov-17 | Sale | 18,367,300 | $2.75 | $50,510,200.00 | (100%) 18.37M to 0 | |
| 14-Aug-17 4:47 PM View: | Vitullo Nicole Director | Achillion Pharmaceuticals, ... (ACHN) | 10-Aug-17 | Payment of Exercise | 1,727,680 | $5.06 | $8,742,060.00 | (33%) 5.2M to 3.47M | |
| 14-Aug-17 4:47 PM View: | Vitullo Nicole Director | Achillion Pharmaceuticals, ... (ACHN) | 10-Aug-17 | Option Exercise | 2,811,240 | $3.11 | $8,750,000.00 | 118% 2.39M to 5.2M | |
| 30-Jun-17 4:28 PM View: | Fisherman Jason S Director | Achillion Pharmaceuticals, ... (ACHN) | 28-Jun-17 | txn.W.title | 1,500 | -- | -- | 3% 50.0K to 51.5K | |
| 23-Dec-16 10:09 AM View: | Fisherman Jason S Director | Achillion Pharmaceuticals, ... (ACHN) | 22-Dec-16 | Market Purchase | 10,000 | $3.96 | $39,600.00 | 25% 40.0K to 50.0K | (40%) |
| 05-Dec-16 5:16 PM View: | Fenton Mary Kay Chief Financial Officer | Achillion Pharmaceuticals, ... (ACHN) | 05-Dec-16 | Market Purchase | 2,500 | $4.11 | $10,275.00 | 100% 0 to 2.5K | (42%) |
| 05-Dec-16 5:18 PM View: | Truitt Joseph Chief Commercial Officer | Achillion Pharmaceuticals, ... (ACHN) | 02-Dec-16 | Market Purchase | 3,500 | $4.06 | $14,210.00 | 100% 0 to 3.5K | (41%) |
| 05-Dec-16 5:17 PM View: | Manning Martha E EVP, General Counsel | Achillion Pharmaceuticals, ... (ACHN) | 02-Dec-16 | Market Purchase | 2,500 | $4.09 | $10,225.00 | 100% 0 to 2.5K | (42%) |
| 05-Dec-16 5:15 PM View: | Barrish Joel C Chief Scientific Officer | Achillion Pharmaceuticals, ... (ACHN) | 02-Dec-16 | Market Purchase | 2,500 | $4.06 | $10,150.00 | 100% 0 to 2.5K | (41%) |
| 05-Dec-16 5:16 PM View: | Deshpande Milind Chief Executive Officer Director | Achillion Pharmaceuticals, ... (ACHN) | 02-Dec-16 | Market Purchase | 2,500 | $4.06 | $10,150.00 | 100% 0 to 2.5K | (41%) |
| 30-Dec-15 4:26 PM View: | Apelian David Chief Medical Officer | Achillion Pharmaceuticals, ... (ACHN) | 30-Dec-15 | Option Exercise | 10,000 | $3.02 | $30,200.00 | 100% 0 to 10.0K | |
| 30-Dec-15 4:26 PM View: | Apelian David Chief Medical Officer | Achillion Pharmaceuticals, ... (ACHN) | 30-Dec-15 | Market Option Sale | 10,000 | $10.50 | $105,000.00 | (100%) 10.0K to 0 | 77% |
| 30-Dec-15 4:25 PM View: | Fenton Mary Kay Chief Financial Officer | Achillion Pharmaceuticals, ... (ACHN) | 28-Dec-15 | Market Option Sale | 43,500 | $10.08 | $438,480.00 | (100%) 43.5K to 0 | 76% |
| 30-Dec-15 4:25 PM View: | Fenton Mary Kay Chief Financial Officer | Achillion Pharmaceuticals, ... (ACHN) | 28-Dec-15 | Option Exercise | 43,500 | $1.05 | $45,675.00 | 100% 0 to 43.5K | |
| 12-Nov-15 4:54 PM View: | Vitullo Nicole Director | Achillion Pharmaceuticals, ... (ACHN) | 11-Nov-15 | Market Sale | 50,000 | $10.31 | $515,500.00 | (2%) 2.44M to 2.39M | 77% |
| 12-Nov-15 4:54 PM View: | Vitullo Nicole Director | Achillion Pharmaceuticals, ... (ACHN) | 10-Nov-15 | Market Sale | 179,074 | $10.43 | $1,867,740.00 | (7%) 2.62M to 2.44M | 77% |
| 12-Nov-15 4:54 PM View: | Vitullo Nicole Director | Achillion Pharmaceuticals, ... (ACHN) | 09-Nov-15 | Market Sale | 320,926 | $10.01 | $3,212,470.00 | (11%) 2.94M to 2.62M | 76% |
| 29-Sep-15 5:21 PM View: | Vitullo Nicole Director | Achillion Pharmaceuticals, ... (ACHN) | 25-Sep-15 | Market Sale | 9,310 | $8.22 | $76,528.20 | (< 1%) 2.95M to 2.94M | 71% |
| 18-Aug-15 6:07 PM View: | Vitullo Nicole Director | Achillion Pharmaceuticals, ... (ACHN) | 18-Aug-15 | Acquisition (other) | 31,431 | -- | -- | 6% 529.84K to 561.27K | |
| 18-Aug-15 6:07 PM View: | Vitullo Nicole Director | Achillion Pharmaceuticals, ... (ACHN) | 18-Aug-15 | Disposition (other) | 483,521 | -- | -- | (86%) 561.27K to 77.75K | |
| 18-Aug-15 6:07 PM View: | Vitullo Nicole Director | Achillion Pharmaceuticals, ... (ACHN) | 14-Aug-15 | Market Sale | 37,843 | $7.51 | $284,201.00 | (7%) 567.68K to 529.84K | 68% |
| 22-May-15 5:11 PM View: | Vitullo Nicole Director | Achillion Pharmaceuticals, ... (ACHN) | 21-May-15 | Disposition (other) | 1,700,000 | -- | -- | (33%) 5.14M to 3.44M | |
| 22-May-15 5:11 PM View: | Vitullo Nicole Director | Achillion Pharmaceuticals, ... (ACHN) | 21-May-15 | Acquisition (other) | 222,630 | -- | -- | 5% 4.92M to 5.14M | |
| 23-Jan-15 5:15 PM View: | Fenton Mary Kay EVP and CFO | Achillion Pharmaceuticals, ... (ACHN) | 23-Jan-15 | Market Option Sale | 13,125 | $16.00 | $210,000.00 | (100%) 13.13K to 0 | 85% |
| 23-Jan-15 5:15 PM View: | Fenton Mary Kay EVP and CFO | Achillion Pharmaceuticals, ... (ACHN) | 23-Jan-15 | Option Exercise | 13,125 | $4.00 | $52,500.00 | 100% 0 to 13.13K | |
| 23-Jan-15 5:15 PM View: | Deshpande Milind President and CEO Director | Achillion Pharmaceuticals, ... (ACHN) | 21-Jan-15 | Market Option Sale | 100,000 | $15.00 | $1,500,000.00 | (100%) 100.0K to 0 | 84% |
| 23-Jan-15 5:15 PM View: | Deshpande Milind President and CEO Director | Achillion Pharmaceuticals, ... (ACHN) | 21-Jan-15 | Option Exercise | 100,000 | $3.02 | $302,000.00 | 100% 0 to 100.0K | |
| 01-Oct-14 5:12 PM View: | Ra Capital Management, LLC | Achillion Pharmaceuticals, ... (ACHN) | 30-Sep-14 | Market Sale | 1,111,000 | $10.05 | $11,163,800.00 | (14%) 7.81M to 6.7M | 76% |
